The Food and Drug Administration today issued a request for
News
Latest
The AHA Sept. 29 asked the Trump administration to provide exemptions for health care personnel from the proclamation issued Sept. 19 announcing changes to the H-1B visa program.
The AHA Sept. 29 sent recommendations to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services to help ensure insurance plans adhere to the agencies’ health insurer pledge to reform prior authorization processes.
The Office of Science and Technology Policy issued a request for information Sept. 26 seeking feedback on federal regulations that hinder AI development, deployment, or adoption.
The AHA urged the Department of Homeland Security today to maintain “duration of status” as an authorized period of stay for the nearly 17,000 physicians nationwide with J-1 visas who are participating in residency and fellowship programs.
The Centers for Medicare & Medicaid Services announced Sept. 26 that average premiums for Medicare Advantage and Part D would decline slightly in 2026.
In this Leadership Dialogue, I’m joined by Jackie Gerhart, M.D., chief medical officer of Epic and a practicing family medicine physician.
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a company is building its pharmaceutical manufacturing plant in America.
States have until Sept. 30 to submit an optional letter of intent to the Centers for Medicare & Medicaid Services indicating they plan to apply to the Rural Health Transformation Program.
The Dr. Lorna Breen Heroes’ Foundation has recognized 60 licensure boards and 1,850 hospitals, health systems and other care facilities for changing invasive and stigmatizing mental health questions in their licensing applications.
SUD is a medical condition marked by a compulsive use of a substance despite harmful consequences.
Ashley Thompson, AHA senior vice president of public policy analysis and development, participated in a panel discussion during Modern Healthcare's Leadership Summit in Washington, D.C. on Sept. 25.
The AHA Sept. 24 expressed support for the Medical Student Education Authorization Act (H.R. 5428), legislation introduced in the House Sept. 17 that would authorize a federal program to award grants to public institutes of higher education to expand or support graduate education for physicians. It particularly focuses on states with the most severe primary care provider shortages.
The Department of Commerce Sept. 24 released a notice seeking public comment on an investigation it launched Sept. 2 on imports of personal protective equipment, medical consumables and medical equipment under Section 232 of the Trade Expansion Act of 1962.
The Centers for Disease Control and Prevention Sept. 24 released its annual report on national sexually transmitted disease data, reporting a 9% decline in STD cases in 2024 compared to 2023.
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a potentially deformed a-traumatic tip.
An AHA blog published Sept. 16 highlights programs and practices by Boston Medical Center leaders and staff that support residents’ mental health, emotional well-being and resilience.
The AHA’s American Organization for Nursing Leadership will host its virtual Nurse Manager Institute on Oct. 30, Nov. 6 and Nov. 13.
The Department of Homeland Security today released a proposed